title: Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity.
abstract: BACKGROUND
  The impact of dairy intake on cardiometabolic risk factors associated with metabolic syndrome (MetS) needs further research.
  
  
  OBJECTIVE
  To investigate the impact of milk consumption on a wide array of cardiometabolic risk factors associated with MetS (blood lipids, cholesterol homeostasis, glucose homeostasis, systemic inflammation, blood pressure, endothelial function) in postmenopausal women with abdominal obesity.
  
  
  METHODS
  In this randomized, crossover study, 27 women with abdominal obesity consumed two 6-week diets based on the National Cholesterol Education Program (NCEP), one with 3.2 servings/d of 2% fat milk per 2000 kcal (MILK) and one without milk or other dairy (NCEP). The macronutrient composition of both diets was comparable (55% carbohydrates, 15% proteins, 30% fat and 10% saturated fat).
  
  
  RESULTS
  The MILK diet had no significant effect on LDL-C, triglycerides, LDL size, CRP and cell adhesion molecule concentrations and on indicators of insulin sensitivity. The MILK diet reduced HDL-C, adiponectin, endothelin and fasting glucose levels as well blood pressure (all P ≤ 0.01), but those changes were comparable to those seen with the NCEP milk-free diet (all between-diet P ≥ 0.07). Finally, the MILK diet was associated with lower VLDL apolipoprotein B fractional catabolic rate (-13.4%; P = 0.04) and plasma sterol concentrations (-12.0%; P = 0.04) compared with the control NCEP milk-free diet.
  
  
  CONCLUSIONS
  These data suggest that short-term consumption of low fat milk in the context of a prudent NCEP diet has no favorable nor deleterious effect on cardiometabolic risk factors associated with MetS in postmenopausal women with abdominal obesity.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Drouin-Chartier
authors.forename: Josée
authors.initials: J
authors.lastname: Gagnon
authors.forename: Marie-Ève
authors.initials: MÈ
authors.lastname: Labonté
authors.forename: Sophie
authors.initials: S
authors.lastname: Desroches
authors.forename: Amélie
authors.initials: A
authors.lastname: Charest
authors.forename: Geneviève
authors.initials: G
authors.lastname: Grenier
authors.forename: Sylvie
authors.initials: S
authors.lastname: Dodin
authors.forename: Simone
authors.initials: S
authors.lastname: Lemieux
authors.forename: Patrick
authors.initials: P
authors.lastname: Couture
authors.affiliation: Institute of Nutrition and Functional Foods (INAF), Laval University, Quebec, QC G1V 0A6, Canada. benoit.lamarche@inaf.ulaval.ca.
authors.forename: Benoît
authors.initials: B
authors.lastname: Lamarche
mesh_terms: D000368:Aged; D000818:Animals; D001055:Apolipoproteins B / Q000097:blood; D001794:Blood Pressure; D002318:Cardiovascular Diseases; D002784:Cholesterol / Q000097:blood; D018592:Cross-Over Studies; D003611:Dairy Products; D004032:Diet; D005247:Feeding Behavior; D005260:Female; D006801:Humans; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D024821:Metabolic Syndrome / Q000150:complications / Q000503:physiopathology*; D008875:Middle Aged; D008892:Milk; D056128:Obesity, Abdominal / Q000150:complications / Q000503:physiopathology*; D017698:Postmenopause; D012307:Risk Factors; D013261:Sterols / Q000097:blood; D055105:Waist Circumference
chemical_list: D001055:Apolipoproteins B; D008055:Lipids; D008079:Lipoproteins, VLDL; D013261:Sterols; D002784:Cholesterol